Franco Iafrate
Sapienza University of Rome
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Franco Iafrate.
JAMA Internal Medicine | 2008
Cesare Hassan; Perry J. Pickhardt; Andrea Laghi; Daniel Kim; Angelo Zullo; Franco Iafrate; Lorenzo Di Giulio; Sergio Morini
BACKGROUND In addition to detecting colorectal neoplasia, abdominal computed tomography (CT) with colonography technique (CTC) can also detect unsuspected extracolonic cancers and abdominal aortic aneurysms (AAA).The efficacy and cost-effectiveness of this combined abdominal CT screening strategy are unknown. METHODS A computerized Markov model was constructed to simulate the occurrence of colorectal neoplasia, extracolonic malignant neoplasm, and AAA in a hypothetical cohort of 100,000 subjects from the United States who were 50 years of age. Simulated screening with CTC, using a 6-mm polyp size threshold for reporting, was compared with a competing model of optical colonoscopy (OC), both without and with abdominal ultrasonography for AAA detection (OC-US strategy). RESULTS In the simulated population, CTC was the dominant screening strategy, gaining an additional 1458 and 462 life-years compared with the OC and OC-US strategies and being less costly, with a savings of
Alimentary Pharmacology & Therapeutics | 2009
Cesare Hassan; Perry J. Pickhardt; Dh Kim; E. Di Giulio; Angelo Zullo; Andrea Laghi; A. Repici; Franco Iafrate; John Osborn; Bruno Annibale
266 and
American Journal of Roentgenology | 2008
Perry J. Pickhardt; Cesare Hassan; Andrea Laghi; Angelo Zullo; David H. Kim; Franco Iafrate; Sergio Morini
449 per person, respectively. The additional gains for CTC were largely due to a decrease in AAA-related deaths, whereas the modeled benefit from extracolonic cancer downstaging was a relatively minor factor. At sensitivity analysis, OC-US became more cost-effective only when the CTC sensitivity for large polyps dropped to 61% or when broad variations of costs were simulated, such as an increase in CTC cost from
Gut | 2015
Cristiano Spada; Cesare Hassan; Brunella Barbaro; Franco Iafrate; Paola Cesaro; Lucio Petruzziello; Leonardo Minelli Grazioli; Carlo Senore; Gabriella Brizi; Isabella Costamagna; Giuseppe Alvaro; Marcella Iannitti; Marco Salsano; Maria Ciolina; Andrea Laghi; Lorenzo Bonomo; Guido Costamagna
814 to
American Journal of Roentgenology | 2008
Perry J. Pickhardt; Cesare Hassan; Andrea Laghi; Angelo Zullo; David H. Kim; Franco Iafrate; Sergio Morini
1300 or a decrease in OC cost from
Topics in Magnetic Resonance Imaging | 2002
Andrea Laghi; Pasquale Paolantonio; Franco Iafrate; Fiorella Altomari; Carlo Miglio; Roberto Passariello
1100 to
Colorectal Disease | 2005
Mario Ferri; Andrea Laghi; P. Mingazzini; Franco Iafrate; L. Meli; F. Ricci; Roberto Passariello; Vincenzo Ziparo
500. With the OC-US approach, suboptimal compliance had a strong negative influence on efficacy and cost-effectiveness. The estimated mortality from CT-induced cancer was less than estimated colonoscopy-related mortality (8 vs 22 deaths), both of which were minor compared with the positive benefit from screening. CONCLUSION When detection of extracolonic findings such as AAA and extracolonic cancer are considered in addition to colorectal neoplasia in our model simulation, CT colonography is a dominant screening strategy (ie, more clinically effective and more cost-effective) over both colonoscopy and colonoscopy with 1-time ultrasonography.
European Radiology | 2006
Valeria Panebianco; Hektor Grazhdani; Franco Iafrate; M. Petroni; Michele Anzidei; Andrea Laghi; Roberto Passariello
Background The impact of not referring sub‐centimetre polyps identified at CT colonography upon the efficacy of colorectal cancer screening remains uncertain.
Radiology | 2009
Cesare Hassan; M. G. Myriam Hunink; Andrea Laghi; Perry J. Pickhardt; Angelo Zullo; David H. Kim; Franco Iafrate; Emilio Di Giulio
OBJECTIVE The objective of this study was to assess the clinical and economic impact of colonoscopic referral for small and diminutive polyps detected at CT colonography (CTC) screening. MATERIALS AND METHODS A decision analysis model was constructed incorporating the expected polyp distribution, advanced adenoma prevalence, colorectal cancer (CRC) risk, CTC performance, and costs related to CRC screening and treatment. The model conservatively assumed that CRC risk was independent of advanced adenoma size. The number of diminutive (< or = 5 mm), small (6-9 mm), and large (> or = 10 mm) CTC-detected polyps needed to be removed to detect one advanced adenoma or prevent one CRC over a 10-year time horizon was calculated. The cost-effectiveness of polypectomy was also assessed. RESULTS The estimated 10-year CRC risk for unresected diminutive, small, and large polyps was 0.08%, 0.7%, and 15.7%, respectively. The number of diminutive, small, and large polyps needed to be removed to avoid leaving behind one advanced adenoma was 562, 71, and 2.5, respectively; similarly, 2,352, 297, and 10.7 polypectomies would be needed, respectively, to prevent one CRC over 10 years. The incremental cost-effectiveness ratio of removing all diminutive and small CTC-detected polyps was
Radiology | 2009
Daniele Regge; Cesare Hassan; Perry J. Pickhardt; Andrea Laghi; Angelo Zullo; David H. Kim; Franco Iafrate; Sergio Morini
464,407 and